Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Feng Huang

Showing results (31-40 of 286) with videos related to

Pageof 29
Sort By:
The Kaohsiung Journal of Medical Sciences|March 3, 2021
Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinomaZu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|February 10, 2022
Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expressionZu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Journal of Gastroenterology and Hepatology|March 3, 2025
Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg-Negative Chronic Hepatitis BCheng-Hao Tseng, Teng-Yu Lee, Chi-Yi Chen, et al.
Clinical and Molecular Hepatology|December 15, 2020
Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinomaChing-Chih Lin, Ta-Wei Liu, Ming-Lun Yeh, et al.
Plos One|July 8, 2014
Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapyMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
Journal of the Chinese Medical Association : JCMA|December 9, 2017
Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resectionChia-Yen Dai, Ching-Yeh Lin, Pei-Chien Tsai, et al.
Journal of Clinical Medicine|September 9, 2023
Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic MalignanciesChien-Tzu Huang, Ching-Ping Lee, Tzu-Yin Chen, et al.
Medicine|March 26, 2016
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese PatientsChi-Ming Tai, Chih-Kun Huang, Hung-Pin Tu, et al.
Scientific Reports|October 12, 2018
Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antiviralsChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
European Journal of Gastroenterology & Hepatology|October 12, 2018
Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsiesTa-Ya Lin, Ming-Lun Yeh, Chung-Feng Huang, et al.
Pageof 29

Showing results (31-40 of 286) with videos related to

Sort By:
Pageof 29
The Kaohsiung Journal of Medical Sciences|March 3, 2021
Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinomaZu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|February 10, 2022
Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expressionZu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
Journal of Gastroenterology and Hepatology|March 3, 2025
Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg-Negative Chronic Hepatitis BCheng-Hao Tseng, Teng-Yu Lee, Chi-Yi Chen, et al.
Clinical and Molecular Hepatology|December 15, 2020
Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinomaChing-Chih Lin, Ta-Wei Liu, Ming-Lun Yeh, et al.
Plos One|July 8, 2014
Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapyMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
Journal of the Chinese Medical Association : JCMA|December 9, 2017
Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resectionChia-Yen Dai, Ching-Yeh Lin, Pei-Chien Tsai, et al.
Journal of Clinical Medicine|September 9, 2023
Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic MalignanciesChien-Tzu Huang, Ching-Ping Lee, Tzu-Yin Chen, et al.
Medicine|March 26, 2016
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese PatientsChi-Ming Tai, Chih-Kun Huang, Hung-Pin Tu, et al.
Scientific Reports|October 12, 2018
Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antiviralsChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
European Journal of Gastroenterology & Hepatology|October 12, 2018
Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsiesTa-Ya Lin, Ming-Lun Yeh, Chung-Feng Huang, et al.
Pageof 29